Julz Pharma

JULZ PHARMA IDENTIFIES AND SOLICITS TECHNOLOGY PRIOR INFLECTION POINT IN US AND EUROPE FOR CHINA RIGHTS Julz Pharma leverages the experience and expertise of its management team in dealings with Chinese partners and market An emphasis on Innovation A bridge between China and advanced technology companies in the US and EU Provides all aspects of partnering activities and end to end R&D Strategy, including fund raising, due diligence, drug/device development and licensing, M&A negotiations Headquartered in the U.S. Operates under standard U.S. legal terms and conditions Strong understanding of the U.S. and China markets